Bio-Rad Laboratories Net Profit Margin 2010-2025 | BIO

Current and historical net profit margin for Bio-Rad Laboratories (BIO) from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. Bio-Rad Laboratories net profit margin for the three months ending March 31, 2025 was .
Bio-Rad Laboratories Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2025-03-31 $2.54B $-2.16B -85.20%
2024-12-31 $2.57B $-1.84B -71.86%
2024-09-30 $2.58B $-0.78B -30.16%
2024-06-30 $2.56B $-1.33B -51.72%
2024-03-31 $2.61B $-0.32B -12.36%
2023-12-31 $2.67B $-0.64B -23.85%
2023-09-30 $2.72B $-0.16B -5.85%
2023-06-30 $2.77B $-0.43B -15.46%
2023-03-31 $2.78B $-0.19B -6.87%
2022-12-31 $2.80B $-3.63B -129.44%
2022-09-30 $2.81B $-6.02B -214.62%
2022-06-30 $2.87B $-1.93B -67.19%
2022-03-31 $2.90B $-0.09B -3.11%
2021-12-31 $2.92B $4.25B 145.54%
2021-09-30 $2.98B $6.67B 223.69%
2021-06-30 $2.88B $4.05B 140.73%
2021-03-31 $2.70B $4.11B 151.98%
2020-12-31 $2.55B $3.81B 149.80%
2020-09-30 $2.38B $3.52B 147.90%
2020-06-30 $2.29B $1.95B 84.83%
2020-03-31 $2.33B $1.58B 67.77%
2019-12-31 $2.31B $1.76B 76.04%
2019-09-30 $2.31B $0.38B 16.31%
2019-06-30 $2.29B $0.90B 39.49%
2019-03-31 $2.29B $0.57B 25.00%
2018-12-31 $2.29B $0.37B 15.94%
2018-09-30 $2.29B $1.28B 55.67%
2018-06-30 $2.28B $1.03B 45.12%
2018-03-31 $2.21B $0.77B 34.67%
2017-12-31 $2.16B $0.12B 5.65%
2017-09-30 $2.11B $0.02B 0.76%
2017-06-30 $2.09B $0.01B 0.58%
2017-03-31 $2.10B $0.03B 1.19%
2016-12-31 $2.07B $0.03B 1.21%
2016-09-30 $2.07B $0.09B 4.55%
2016-06-30 $2.03B $0.09B 4.58%
2016-03-31 $2.02B $0.10B 5.10%
2015-12-31 $2.02B $0.11B 5.40%
2015-09-30 $2.05B $0.10B 4.98%
2015-06-30 $2.11B $0.10B 4.60%
2015-03-31 $2.14B $0.10B 4.72%
2014-12-31 $2.18B $0.09B 4.14%
2014-09-30 $2.18B $0.08B 3.72%
2014-06-30 $2.15B $0.06B 2.88%
2014-03-31 $2.14B $0.07B 3.03%
2013-12-31 $2.13B $0.08B 3.66%
2013-09-30 $2.10B $0.09B 4.33%
2013-06-30 $2.10B $0.14B 6.72%
2013-03-31 $2.08B $0.15B 7.39%
2012-12-31 $2.07B $0.17B 7.97%
2012-09-30 $2.05B $0.18B 8.90%
2012-06-30 $2.06B $0.19B 8.97%
2012-03-31 $2.08B $0.18B 8.53%
2011-12-31 $2.07B $0.18B 8.63%
2011-09-30 $2.06B $0.19B 9.09%
2011-06-30 $2.01B $0.19B 9.24%
2011-03-31 $1.96B $0.18B 9.39%
2010-12-31 $1.93B $0.19B 9.65%
2010-09-30 $1.89B $0.16B 8.26%
2010-06-30 $1.88B $0.15B 7.99%
2010-03-31 $1.84B $0.15B 8.17%
2009-12-31 $1.78B $0.15B 8.13%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.887B $2.567B
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.781B 27.87
Boston Scientific (BSX) United States $152.324B 38.13
Stryker (SYK) United States $149.641B 31.29
EssilorLuxottica (ESLOY) France $137.721B 0.00
Medtronic (MDT) Ireland $114.146B 16.18
Lonza Group Ag (LZAGY) Switzerland $51.237B 0.00
Haleon (HLN) United Kingdom $45.147B 25.77
ResMed (RMD) United States $37.534B 28.19
GE HealthCare Technologies (GEHC) United States $34.575B 16.42
Agilent Technologies (A) United States $34.457B 22.46
Terumo (TRUMY) Japan $25.051B 32.54
Koninklijke Philips (PHG) Netherlands $23.235B 16.30
Insulet (PODD) United States $20.934B 82.17
Zimmer Biomet Holdings (ZBH) United States $18.835B 12.10
Baxter (BAX) United States $15.298B 11.42
Smith & Nephew SNATS (SNN) United Kingdom $13.441B 0.00
Demant (WILYY) Denmark $8.971B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Lantheus Holdings (LNTH) United States $5.776B 14.57
Prestige Consumer Healthcare (PBH) United States $3.897B 17.41
Perrigo (PRGO) Ireland $3.742B 9.48
Haemonetics (HAE) United States $3.724B 16.96
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.454B 28.70
ICU Medical (ICUI) United States $3.341B 24.63
QuidelOrtho (QDEL) United States $2.135B 14.68
LeMaitre Vascular (LMAT) United States $1.910B 42.70
AtriCure (ATRC) United States $1.580B 0.00
Acuren (TIC) United States $1.397B 0.00
Phibro Animal Health (PAHC) United States $1.272B 16.26
Green Thumb Industries (GTBIF) United States $1.249B 28.09
AdaptHealth (AHCO) United States $1.247B 12.66
Neogen (NEOG) United States $1.194B 15.28
BioLife Solutions (BLFS) United States $1.068B 0.00
InMode (INMD) Israel $0.963B 9.70
Kestra Medical Technologies (KMTS) United States $0.791B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.703B 0.00
Tilray Brands (TLRY) Canada $0.679B 0.00
Curaleaf Holdings (CURLF) Canada $0.670B 0.00
Owens & Minor (OMI) United States $0.667B 5.53
Evolus (EOLS) United States $0.623B 0.00
CeriBell (CBLL) United States $0.596B 0.00
Capricor Therapeutics (CAPR) United States $0.522B 0.00
Valneva SE (VALN) France $0.502B 0.00
Surmodics (SRDX) United States $0.441B 0.00
SNDL (SNDL) Canada $0.373B 0.00
VAREX IMAGING (VREX) United States $0.347B 12.77
Sanuwave Health (SNWV) United States $0.308B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Quanterix (QTRX) United States $0.295B 0.00
Cresco Labs (CRLBF) United States $0.291B 0.00
Cerus (CERS) United States $0.285B 0.00
Viemed Healthcare (VMD) United States $0.276B 23.27
Sanara MedTech (SMTI) United States $0.269B 0.00
ZimVie (ZIMV) United States $0.264B 12.01
Aurora Cannabis (ACB) Canada $0.257B 76.17
Brainsway (BWAY) Israel $0.246B 65.00
Canopy Growth (CGC) Canada $0.232B 0.00
OraSure Technologies (OSUR) United States $0.227B 0.00
Biote (BTMD) United States $0.225B 6.34
Verano Holdings (VRNOF) United States $0.210B 0.00
Omeros (OMER) United States $0.198B 0.00
Organigram Global (OGI) Canada $0.193B 0.00
High Tide (HITI) Canada $0.190B 0.00
TriSalus Life Sciences (TLSI) United States $0.190B 0.00
Utah Medical Products (UTMD) United States $0.186B 15.15
Vireo Growth (VREOF) United States $0.150B 0.00
Exagen (XGN) United States $0.145B 0.00
FitLife Brands (FTLF) United States $0.126B 15.53
TerrAscend (TSNDF) Canada $0.104B 0.00
MacroGenics (MGNX) United States $0.100B 0.00
Fonar (FONR) United States $0.096B 12.37
Jin Medical (ZJYL) China $0.093B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
Apyx Medical (APYX) United States $0.086B 0.00
Quipt Home Medical (QIPT) United States $0.082B 0.00
Veru (VERU) United States $0.081B 0.00
Jushi Holdings (JUSHF) United States $0.072B 0.00
Zynex (ZYXI) United States $0.072B 0.00
InterCure (INCR) Israel $0.072B 0.00
Agape ATP (ATPC) $0.071B 0.00
Cytosorbents (CTSO) United States $0.070B 0.00
ImmuCell (ICCC) United States $0.061B 0.00
Rockwell Medical (RMTI) United States $0.041B 0.00
Nephros (NEPH) United States $0.040B 53.29
Modular Medical (MODD) United States $0.039B 0.00
United-Guardian (UG) United States $0.037B 12.82
Safety Shot (SHOT) United States $0.033B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.016B 0.00
IM Cannabis (IMCC) Canada $0.014B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00